More in detail, PTEN overexpression observed in LAML samples is controversial as different studies demonstrated that PTEN acts as a tumor suppressor in myeloid leukemia and its expression levels are lower in LAML samples compared to controls [174, 175]. This evidence concerns the gene PTEN and neoplasm.